GMHC Treat Issues. 1995 May;9(5):7-8, 12.
Other therapies for wasting.
Smart T.
AIDS: Individuals with wasting syndrome lose muscle or lean body mass rather than   
body fat. Several possible alternatives to the approved drugs for AIDS-related    
wasting are discussed. Ketotifen, an antihistamine approved in Europe, is a TNF    
inhibitor. Anabolic steroids are testosterone derivatives designed to increase    
strength and muscle. Although there are anecdotal reports of success with these    
steroids, their long-term safety and efficacy have yet to be established in    
placebo-controlled studies. An ongoing study at Mt. Sinai shows a statistically    
significant effect on lean body mass in the first twelve men to complete the    
study. Dehydroepiandrosterone (DHEA) is a hormone produced by the adrenal gland.     
Although its role in the body is poorly understood; it may have immunologic    
effects, and appears to influence metabolism. There have been no studies of    
DHEA's effect on weight or body composition in people with AIDS-related wasting.     
A study combining ketotifen and oxymetholone, the oral anabolic steroid, was    
presented at the Ninth International AIDS Conference. Preliminary data from a    
study combining ketotifen and oxymetholone showed that 18 out of 22 patients    
gained an average of 11.4 pounds after treatment of an average of 3.9 weeks.    
Finally, a trial of smoked marijuana versus the oral drug marinol for    
AIDS-related wasting syndrome may be canceled. The Drug Enforcement    
Administration (DEA) and the National Institute of Drug Abuse (NIDA) rejected the    
Community Consortium of San Francisco's proposal to obtain officially sanctioned     
cannabis.











 
 
0 comments:
Post a Comment